Discontinuation report EXTAVIA

Last updated on 2022-02-11 History
Report ID 152532
Drug Identification Number 02337819
Brand name EXTAVIA
Common or Proper name EXTAVIA 30G / VIAL 0.3MG (X15)
Company Name NOVARTIS PHARMACEUTICALS CANADA INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) INTERFERON BETA-1B
Strength(s) 0.3MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size X15
ATC code L03AB
ATC description IMMUNOSTIMULANTS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2022-02-18
Actual discontinuation date 2022-02-10
Remaining supply date 2022-08-30
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 385 BOUCHARD BLVD
DORVAL, QUEBEC
CANADA H9S 1A9
Company contact information customer.relations@novartis.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2022-02-11 English Compare
v4 2022-02-10 French Compare
v3 2022-02-10 English Compare
v2 2022-01-12 French Compare
v1 2022-01-12 English Compare

Showing 1 to 5 of 5